Pages that link to "Q34146791"

The following pages link to Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference (Q34146791):

Displaying 100 items.

• Papillomavirus genome structure, expression, and post-transcriptional regulation (Q22255483) (← links)
• Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation (Q24311308) (← links)
• The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase (Q24521626) (← links)
• The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation (Q24545831) (← links)
• JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process? (Q24634312) (← links)
• A bi-functional siRNA construct induces RNA interference and also primes PCR amplification for its own quantification (Q24811889) (← links)
• Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer (Q26799484) (← links)
• Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer (Q27020978) (← links)
• Structural Insights into a Wildtype Domain of the Oncoprotein E6 and Its Interaction with a PDZ Domain (Q27677967) (← links)
• Utility of microRNAs and siRNAs in cervical carcinogenesis (Q28083010) (← links)
• Killing the messenger: short RNAs that silence gene expression (Q28207880) (← links)
• Sonoporation delivery of monoclonal antibodies against human papillomavirus 16 E6 restores p53 expression in transformed cervical keratinocytes (Q28485410) (← links)
• A Small Molecule Inhibitor Selectively Induces Apoptosis in Cells Transformed by High Risk Human Papilloma Viruses (Q28550190) (← links)
• Inhibition of papillomavirus protein function in cervical cancer cells by intrabody targeting (Q33228392) (← links)
• Short interfering RNA (siRNA) as a novel therapeutic (Q33243420) (← links)
• Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells (Q33588694) (← links)
• SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53. (Q33727892) (← links)
• Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus (Q34127590) (← links)
• RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells (Q34178401) (← links)
• siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells (Q34227843) (← links)
• Interfering with disease: opportunities and roadblocks to harnessing RNA interference (Q34234252) (← links)
• siRNA therapeutics: big potential from small RNAs (Q34360881) (← links)
• Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains (Q34371320) (← links)
• RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice (Q34437582) (← links)
• RNAi is an antiviral immune response against a dsRNA virus in Drosophila melanogaster. (Q34513161) (← links)
• Docosahexaenoic acid induces the degradation of HPV E6/E7 oncoproteins by activating the ubiquitin-proteasome system. (Q34662232) (← links)
• New molecular targets against cervical cancer (Q34700859) (← links)
• Deregulation of eIF4E: 4E-BP1 in differentiated human papillomavirus-containing cells leads to high levels of expression of the E7 oncoprotein (Q34717857) (← links)
• An RNA aptamer provides a novel approach for the induction of apoptosis by targeting the HPV16 E7 oncoprotein (Q34758890) (← links)
• RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells (Q34977316) (← links)
• Leukemia inhibitory factor downregulates human papillomavirus-16 oncogene expression and inhibits the proliferation of cervical carcinoma cells. (Q35070591) (← links)
• Small molecule inhibitors of human papillomavirus protein - protein interactions (Q35107717) (← links)
• Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells (Q35123537) (← links)
• RNA interference for treating cancers caused by viral infection (Q35144036) (← links)
• Nucleic acid-based immune system: the antiviral potential of mammalian RNA silencing (Q35153871) (← links)
• RNAi as a gene therapy approach (Q35164788) (← links)
• Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein (Q35191416) (← links)
• RNA interference: antiviral weapon and beyond (Q35199493) (← links)
• Functional genomics in virology and antiviral drug discovery (Q35544794) (← links)
• RNA interference: gene silencing in the fast lane (Q35561597) (← links)
• Exposing oncogenic dependencies for cancer drug target discovery and validation using RNAi (Q35561611) (← links)
• RNA interference and human disease (Q35563847) (← links)
• Role of viruses in oral squamous cell carcinoma (Q35569336) (← links)
• Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation (Q35589596) (← links)
• Molecular Mechanism and Potential Targets for Blocking HPV-Induced Lesion Development (Q35636308) (← links)
• Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells (Q35642188) (← links)
• Long (27-nucleotides) small inhibitory RNAs targeting E6 protein eradicate effectively the cervical cancer cells harboring human papilloma virus (Q35649376) (← links)
• Identification and analysis of papillomavirus E2 protein binding sites in the human genome. (Q35666079) (← links)
• Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study (Q35670508) (← links)
• RNA silencing of rotavirus gene expression (Q35739901) (← links)
• Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo (Q35813800) (← links)
• Advances in the development of therapeutic nucleic acids against cervical cancer (Q35842608) (← links)
• Identification and characterization of small molecule antagonists of pRb inactivation by viral oncoproteins (Q35908493) (← links)
• Development of gene-specific double-stranded RNA drugs (Q35932393) (← links)
• Cudrania tricuspidata Stem Extract Induces Apoptosis via the Extrinsic Pathway in SiHa Cervical Cancer Cells (Q35951428) (← links)
• RNA interference--small RNAs effectively fight viral hepatitis (Q35964876) (← links)
• Interfering with cancer: a brief outline of advances in RNA interference in oncology (Q35997754) (← links)
• The role of small RNAs in human diseases: potential troublemaker and therapeutic tools (Q36002359) (← links)
• Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior (Q36095528) (← links)
• The therapeutic potential of RNA interference (Q36237868) (← links)
• Prospects of RNA interference therapy for cancer (Q36337922) (← links)
• Papillomaviruses as targets for cancer gene therapy (Q36337998) (← links)
• HPV-16 E6 promotes cell growth of esophageal cancer via downregulation of miR-125b and activation of Wnt/β-catenin signaling pathway (Q36375628) (← links)
• Targeted treatments for cervical cancer: a review. (Q36384032) (← links)
• E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines (Q36414343) (← links)
• Potential applications of RNA interference technology in the treatment of cancer (Q36429400) (← links)
• RNA interference: its use as antiviral therapy. (Q36440302) (← links)
• Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India (Q36497960) (← links)
• RNA interference for the treatment of papillomavirus disease. (Q36540664) (← links)
• Feasibility of Induction Docetaxel, Cisplatin, 5-Fluorouracil, Cetuximab (TPF-C) Followed by Concurrent Cetuximab Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma (Q36568927) (← links)
• Lack of correlation between predicted and actual off-target effects of short-interfering RNAs targeting the human papillomavirus type 16 E7 oncogene (Q36594145) (← links)
• The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target (Q36616097) (← links)
• Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. (Q36748177) (← links)
• Intrabody strategies for the treatment of human papillomavirus-associated disease (Q36810292) (← links)
• HPV-Based Screening, Triage, Treatment, and Followup Strategies in the Management of Cervical Intraepithelial Neoplasia (Q36830943) (← links)
• Depletion of polycistronic transcripts using short interfering RNAs: cDNA synthesis method affects levels of non-targeted genes determined by quantitative PCR. (Q36937490) (← links)
• Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers (Q36982644) (← links)
• Morphoproteomic evidence of constitutively activated and overexpressed mTOR pathway in cervical squamous carcinoma and high grade squamous intraepithelial lesions. (Q37009828) (← links)
• Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis (Q37024935) (← links)
• Applying small RNA molecules to the directed treatment of human diseases: realizing the potential (Q37030891) (← links)
• Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription (Q37031856) (← links)
• PDZ domains and viral infection: versatile potentials of HPV-PDZ interactions in relation to malignancy (Q37182781) (← links)
• Identification of RNA aptamers that internalize into HPV-16 E6/E7 transformed tonsillar epithelial cells (Q37265632) (← links)
• Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region (Q37331647) (← links)
• Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells (Q37424075) (← links)
• Epstein-Barr virus in human malignancy: a special reference to Epstein-Barr virus associated gastric carcinoma (Q37449248) (← links)
• Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis (Q37579334) (← links)
• Therapeutic opportunities of small interfering RNA. (Q37587437) (← links)
• Marine Streptomyces sp. derived antimycin analogues suppress HeLa cells via depletion HPV E6/E7 mediated by ROS-dependent ubiquitin-proteasome system (Q37630750) (← links)
• The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase (Q37729872) (← links)
• HPV positive neuroendocrine cervical cancer cells are dependent on Myc but not E6/E7 viral oncogenes (Q37738156) (← links)
• p53-based cancer therapy (Q37750115) (← links)
• Oncolytic-adenovirus-expressed RNA interference for cancer therapy (Q37777745) (← links)
• Strategies for tumor-directed delivery of siRNA. (Q37840092) (← links)
• Emerging drugs for cervical cancer. (Q38005222) (← links)
• RNAi-mediated gene silencing in cancer therapy (Q38030982) (← links)
• Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells (Q38299944) (← links)
• Emerging drugs for the treatment of cervical cancer (Q38314157) (← links)
• Blockage of the macrophage migration inhibitory factor expression by short interference RNA inhibited the rejection of an allogeneic tracheal graft (Q38321082) (← links)
• Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site (Q38334641) (← links)